<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01466088</url>
  </required_header>
  <id_info>
    <org_study_id>TC-1734-226-CRD-006</org_study_id>
    <nct_id>NCT01466088</nct_id>
  </id_info>
  <brief_title>Efficacy, Safety, &amp; Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)</brief_title>
  <official_title>Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Targacept Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Targacept Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alzheimer's disease is the most common form of dementia and is the fourth leading cause of
      death among people 65 years of age and older. The global prevalence of the disease will
      increase significantly as the population ages, unless preventative treatments can be
      identified and marketed. The present study seeks to evaluate AZD3480 (TC-1734) compared to an
      approved medication (donepezil) shown to improve cognition and function in patients with
      Alzheimer's disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double blind, positive comparator, randomized, multicenter, parallel group study to
      assess the efficacy, safety, and tolerability of AZD3480 as monotherapy in patients with mild
      to moderate dementia of the Alzheimer's type (AD). Approximately 300 subjects will be
      randomized and divided into 2 cohorts. Actual randomization was 293 subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog)</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in the Clinician Interview-Based Impression of Change plus carer interview [CIBIC-(+)]</measure>
    <time_frame>52 Weeks</time_frame>
    <description>The CIBIC-(+) is a co-primary endpoint with the ADAS-Cog in the United States.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in the Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL)</measure>
    <time_frame>52 Weeks</time_frame>
    <description>The ADCS-ADL is the co-primary endpoint with the ADAS-Cog in Europe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the Neuropsychiatric Inventory (NPI)</measure>
    <time_frame>52 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the Mini-Mental State Examination (MMSE)</measure>
    <time_frame>52 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the Alzheimer's Disease Related Quality of Life (ADRQL)</measure>
    <time_frame>52 Weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">386</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>AZD3480</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Donepezil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Donepezil will be administered at 5 mg daily for 4 weeks and escalated to 10 mg daily for the remainder of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Donepezil</intervention_name>
    <description>Subjects taking donepezil will take 1-2 capsules of 5 mg donepezil and a placebo for AZD3480 (to maintain blind) orally once a day.</description>
    <arm_group_label>Donepezil</arm_group_label>
    <other_name>Aricept</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AZD3480</intervention_name>
    <description>Subjects taking 30 mg AZD3480 will take one capsule of AZD3480 and two capsules of placebo for donepezil (to maintain blind) orally once a day.</description>
    <arm_group_label>AZD3480</arm_group_label>
    <other_name>TC-1734</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. A clinical diagnosis of AD per NINCDS-ADRDA criteria; mild to moderate severity as
             defined by Mini-Mental State Examination (MMSE) scores of 12 to 22.

          2. AD diagnosed at least 12 months prior to Screening, and supported by brain imaging
             studies within 6 months prior to Screening.

          3. Absence of vascular dementia both per AIRENS criteria and as defined by modified
             Hachinski ischemia score (HIS) of &lt;/= 4.

          4. Presence of a caregiver with significant proportion of time in contact with subject
             and who will oversee administration of study drug during the trial

          5. Able to complete test assessments and to sign informed consent with the help of a
             caregiver if needed

        Exclusion Criteria:

          1. Diagnosis or presence of other dementing illnesses

          2. Use of mood stabilizers, antidepressants, anxiolytics, antipsychotics or hypnotics

          3. Treatment within 1 month prior to Screening using cognition-affecting agents (e.g. CNS
             stimulants)

          4. Tobacco user within 4 months prior to Screening

          5. Use of smoking cessation therapy within 4 months prior to Screening

          6. History within past 6 months of alcohol abuse or illicit drug abuse

          7. Unable, even with caregiver assistance, to comply with study procedures in opinion of
             investigator

          8. Myocardial infarction within the 12 months prior to Screening

          9. Hypothyroidism, vitamin B12 or folic acid deficiency

         10. Known systemic infection (HBV, HCV, HIV, TB)

         11. Vascular dementia per NINDS-AIRENS criteria and as defined by a modified Hachinski
             ischemia score (HIS, Appendix 4) score of &gt; 4 (i.e., vascular dementia is consistent
             with a modified HIS &gt; 4).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Tariot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Banner Alzheimer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner Alzheimer Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research</name>
      <address>
        <city>Brooksville</city>
        <state>Florida</state>
        <zip>34601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Clinical</name>
      <address>
        <city>Hallandale Beach</city>
        <state>Florida</state>
        <zip>33009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinic</name>
      <address>
        <city>Chocen</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BRAIN-SOULTHERAPY s.r.o.</name>
      <address>
        <city>Kladno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bialbi.s.r.o. Psychiatrické oddělení</name>
      <address>
        <city>Litoměřice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Psychiatricka Ambulance</name>
      <address>
        <city>Olomouc</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vojenska Nemocnice Psychiatricke oddeleni</name>
      <address>
        <city>Olomouc</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clintrial</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PRAGTIS s.r.o.</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Psychosocialni centrum</name>
      <address>
        <city>Prerov</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crucea Alba - Dr. Oros si Asociatii - Societate Civila Medicala</name>
      <address>
        <city>Oradea</city>
        <zip>410163</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie Sibiu</name>
      <address>
        <city>Sibiu</city>
        <zip>550012</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta SIBIU</name>
      <address>
        <city>Sibiu</city>
        <zip>550166</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta, Clinica Psihiatrie</name>
      <address>
        <city>Timisoara</city>
        <zip>300128</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta, Clinica Neurologie 2</name>
      <address>
        <city>Timisoara</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologicka Ambulancia, s.r.o.</name>
      <address>
        <city>Banska Bystrica</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univerzitna nemocnica Bratislava, Geronto-psychiatrické oddelenie</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KONZILIUM s.r.o.</name>
      <address>
        <city>Dubnica nad Váhom</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologická ambulancia</name>
      <address>
        <city>Krompachy</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dnipropetrovsk Regional Clinical Hospital</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donetsk National Medical University of M. Gorky</name>
      <address>
        <city>Donetsk</city>
        <zip>83003</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donetsk Regional Clinical Psychiatric Hospital</name>
      <address>
        <city>Donetsk</city>
        <zip>83008</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crimean Republican Institution Psychoneurological Dispensary</name>
      <address>
        <city>Kerch</city>
        <zip>98310</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Clinical Hospital Ukrzaliznytsi</name>
      <address>
        <city>Kharkiv</city>
        <zip>61103</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Age Physiology and Pathology of Nervous System; Institute of Gerontology NAMS</name>
      <address>
        <city>Kyiv</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lugansk Regional Clinical Psychoneurological Hospital</name>
      <address>
        <city>Lugansk</city>
        <zip>91045</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lviv National Medical University named after Galytskyy</name>
      <address>
        <city>Lviv</city>
        <zip>79010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lviv Regional Clinical Psychiatric Hospital</name>
      <address>
        <city>Lviv</city>
        <zip>79021</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odessa Regional Psychoneurology Dispensary</name>
      <address>
        <city>Odessa</city>
        <zip>65014</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odessa Regional Psychiatric Hospital # 2</name>
      <address>
        <city>Oleksandrivka</city>
        <zip>67513</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ukrainian Medical Stomatological Academy</name>
      <address>
        <city>Poltava</city>
        <zip>36006</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department #3 of the Kherson Regional Psychiatric Hospital</name>
      <address>
        <city>Stepanovka</city>
        <zip>73488</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>Romania</country>
    <country>Slovakia</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2011</study_first_submitted>
  <study_first_submitted_qc>November 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2011</study_first_posted>
  <disposition_first_submitted>May 11, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>May 11, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">June 3, 2015</disposition_first_posted>
  <last_update_submitted>May 11, 2015</last_update_submitted>
  <last_update_submitted_qc>May 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>AD</keyword>
  <keyword>Dementia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Donepezil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

